Telik
Biopharmaceutical company focused on developing drugs for cancer and inflammatory diseases
Last updated August 25, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Telik was a defunct biopharmaceutical company that developed innovative drugs for cancer and inflammatory diseases. Its most notable candidate was Telcyta (canfosfamide), but clinical trials failed to meet expectations, leading to bankruptcy.
Products and positioning
Cite this profile: Cite the canonical profile. /brand-wiki/telik · Editorial policy · How profiles are compiled